Claya logo

Claya Review

7.1
★★★★☆3.6/5

Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.1/10

Best for: compounded GLP-1 in injectable and oral-tablet forms with named clinicians

Claya scores highest on the strength of its clinical program: drug options and dosing support.

Semaglutide

$149per 4 weeks

Tirzepatide

$199per 4 weeks

Price checked on Claya’s site,

What the monthly price covers

Medication

Included

Provider visits

Not stated

Shipping

Included

Lab work

Not stated

Coaching

Not stated

See plans →

No insurance neededVetted by our editors

Compare top-rated alternatives ↓

Claya is a direct-to-consumer telehealth platform offering compounded semaglutide and tirzepatide in both injectable and oral-tablet forms, a wider format range than most competitors. It publicly names its clinicians and its two compounding pharmacy partners, with a weight-loss money-back guarantee and free expedited shipping included. Monthly plans start at $149 a month for semaglutide and $199 for tirzepatide, shipped every 4 weeks; refills lock at $299/month.

By Eli Marsden · Founding Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
CompoundedOral OptionSemaglutideTirzepatide503A PharmacyFree expedited deliveryNamed medical leadership

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money

Vetted alternatives to Claya

7.7/ 10
Partner

Ro

Best for: FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help

★★★★☆3.9/5

Editorial score · methodology

$149/mosemaglutide
+ required membership
BrandSemaglutideTirzepatideOrforglipron
Get StartedRead full Ro review →
8.3/ 10
Partner

Collective

Best for: the lowest flat medication price if you can absorb an annual membership fee

★★★★☆4.2/5

Editorial score · methodology

$59/mosemaglutide
+ required membership
$69/motirzepatide
+ required membership
CompoundedSemaglutideTirzepatide
Get StartedRead full Collective review →
8.3/ 10
Partner

CoreAge Rx

Best for: lowest-price compounded semaglutide and tirzepatide with one flat price at every dose

★★★★☆4.2/5

Editorial score · methodology

$79/mosemaglutide
“starting at” price
$129/motirzepatide
“starting at” price
CompoundedSemaglutideTirzepatideNAD+SermorelinLegitScript Verified
Get StartedRead full CoreAge Rx review →
Claya logo
3.6 / 5
Our editorial rating
Visit Claya →

from $149/4 wks (billed per 4 weeks) · no insurance needed

Claya at a glance

Type
GLP-1 telehealth provider
Medications
Semaglutide, Tirzepatide
Starting price
$149/4 wks (billed per 4 weeks) (Monthly plan starting at $149 a month for semaglutide, shipped every 4 weeks.)
What's included
Medication · Shipping
FDA status
No FDA warning letter on record

How we scored Claya

Each dimension is scored algorithmically from Claya’s published pricing, drugs offered, verification status, and disclosed inclusions, using the same six-dimension framework we apply to every provider.

Value25%

7.7/10

At $149/mo (per 4 weeks), Claya runs about 17% below the $179 median for GLP-1 providers (each program's lowest listed ongoing monthly price for compounded semaglutide).

Effectiveness25%

7.9/10

Claya offers both semaglutide and tirzepatide, the two GLP-1 molecules with the strongest published weight-loss trial outcomes. An oral/needle-free option is offered for patients who avoid injections.

User Experience15%

6.9/10

Online intake and platform experience; 7 platform features disclosed.

Trust & Safety15%

7.0/10

Core details confirmed by our editors; no FDA warning letters on file.

Accessibility10%

5.8/10

Claya's exact state footprint isn't published. Confirm coverage in your state before signing up.

Support10%

5.6/10

Claya provides standard clinician follow-up; no extended coaching or community program is disclosed.

6scored dimensions
671providers compared

Each checked against the provider’s own site.

Value 25%Effectiveness 25%User Experience 15%Trust & Safety 15%Accessibility 10%Support 10%

Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →

How we verified this Claya review

Last checked October 2026
  • Confirmed current pricing across 4 dose/plan tiers
  • Confirmed what the monthly price does and doesn't include
  • Checked the FDA warning-letter database for enforcement actions
  • Walked the provider's public sign-up flow, stopping before payment

Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records. See the sources below. Editorial confidence in this data: medium.

What we checked

Provider's own pricing page
$149–$379/mo across 4 dose/plan tiers (checked October 2026)
FDA warning-letter register
No letter on file for this provider

What to expect when you sign up with Claya

We walked Claya’s public signup flow in July 2026 to document the process (the steps, pricing transparency, and what’s required) before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)

  1. 1Complete a roughly 3-minute secure online assessment.
  2. 2A licensed provider reviews your profile and creates a treatment plan.
  3. 3If prescribed, medication ships with discreet delivery.
  4. 4Ongoing refill support with reminders and care-team guidance follows.
Price shown before you start
  • Homepage shows starting prices before intake: semaglutide from $149/mo, tirzepatide from $199/mo with select multi-month plans.
  • Price bundles medication (if prescribed), provider review, ongoing support, and shipping.
  • States 'Cancel anytime' for cancellation flexibility.
  • Same-day shipping for approved prescriptions completed before the pharmacy cutoff; times vary by location.

Claya customer support

GLP-1 medications Claya offers

Tap any medication to read our plain-English guide: how it works, dosing, side effects, and what the trials found.

Pricing

Prices re-verified

Monthly plan, shipped every 4 weeks ('Starting at')Compounded
$149per 4 weeks
semaglutide

Monthly plan starting at $149 a month for semaglutide, shipped every 4 weeks.

Oral tablet (first month)Compounded · oral
$279/mo
semaglutide
Monthly plan, shipped every 4 weeks ('Starting at')Compounded
$199per 4 weeks
tirzepatide

Monthly plan starting at $199 a month for tirzepatide, shipped every 4 weeks.

Oral tablet (first month)Compounded · oral
$379/mo
tirzepatide

Ready to get started?

Plans and promotions change often, so check Claya's current pricing and active discounts before you decide.

See Claya pricing →

What we like

  • Two named licensed clinicians (Habashy, NMD MS and Barber, MD PhD), which is rare for compounded GLP-1
  • Two named pharmacy partners with full addresses (RedRock, UT and Healthware, KY)
  • Both injectable and oral-tablet forms offered for semaglutide and tirzepatide
  • Weight-loss money-back guarantee published on the homepage
  • Free expedited shipping included in the monthly price

Watch-outs

  • States-served list not disclosed, so you must check at checkout
  • LegitScript certification status not displayed
  • Corporate legal entity not disclosed on the site or privacy policy
  • Oral compounded tablets have weaker efficacy data than injectable semaglutide
  • Intro pricing is higher at refill ($299), erasing the first-month advantage

Claya in one line: more format choice, named names, but a few blanks left unfilled

Claya is a direct-to-consumer telehealth platform built around one useful idea: it sells compounded semaglutide and tirzepatide in both the usual weekly injection and a swallow-it oral tablet. That dual-format menu is wider than most compounded GLP-1 sellers offer, and Claya pairs it with something the category is usually shy about, since it publishes the names of its prescribing clinicians and its two pharmacy partners. For a shopper who has spent any time on faceless compounding sites, that transparency is the main reason to look here. Still, a handful of the trust details you would want before paying (which states it serves, its certification ID, and even what legal company you are buying from) are not on the site.

How Claya's pricing works (a starting price, shipped every 4 weeks)

Claya's monthly plan lists injectable semaglutide as 'Starting at $149 a month' and tirzepatide as 'Starting at $199 a month', with the medication shipped every 4 weeks. Read those as starting prices rather than a fixed rate: the site shows lower per-month figures only on multi-month plans, and the exact charge is confirmed at checkout. Ask whether you are billed per shipment, because thirteen four-week shipments a year cost more than twelve monthly payments. Oral tablets carry their own, higher starting prices. Claya frames the plan as all-in with no membership or hidden fees, and free expedited shipping is bundled into that monthly price.

Claya also advertises a separate concierge 'membership' tier that costs vastly more, with a four-figure monthly price aimed at a different buyer entirely. It is not the plan most people land on, and you should not confuse it with the standard medication price.

The medications, plus an unusual oral-tablet option

On the injectable side, Claya offers compounded semaglutide and tirzepatide as a once-weekly shot, which is the same delivery method used by the brand-name versions and the form with the strongest evidence behind it. Claya also offers an oral-tablet route for both molecules, a needle-free option that appeals to anyone squeamish about self-injection.

The tablets come with a trade-off. Compounded oral GLP-1 tablets have considerably weaker efficacy data than injectable semaglutide; the gold-standard weight-loss trials were run on the injections, not on compounded pills. The oral format is convenient, but you may be paying a premium for less proven results. If maximum weight loss is the goal, the injection is the better-supported choice.

Claya tells you who is behind the medicine

Most compounded GLP-1 sites keep their clinicians and pharmacies anonymous. Claya names two licensed providers on its homepage (Jennifer Habashy, NMD, MS, and Dr. Michael Barber, MD, PhD), and it names both compounding pharmacy partners with full street addresses: RedRock Pharmacy in St. George, Utah, and Healthware House in Florence, Kentucky. A motivated patient can look up the supply chain instead of taking it on faith.

  • Two named, licensed clinicians behind the prescriptions, which is rare in compounded GLP-1
  • Two named pharmacy partners, each with a physical address you can look up
  • Both injectable and oral-tablet forms for semaglutide and tirzepatide
  • A weight-loss money-back guarantee published right on the homepage
  • Free expedited shipping folded into the monthly price

Where Claya leaves you guessing

For all that openness, Claya withholds some basics. It does not publish the list of states it serves, so you only find out whether you qualify once you are deep in checkout. It does not display a LegitScript certification ID, a credential reputable telehealth pharmacies usually show off. And neither the site nor the privacy policy names the corporate legal entity you are contracting with. The privacy policy lists a Des Moines, Iowa, address and operations run out of Henderson, Nevada, but no LLC or Inc. behind the brand. One alternative is JustAnswer Weight Loss, which is run by the JustAnswer expert-advice platform and charges one price at every dose with the physician visit included. None of these is a red flag on its own, but together they are the difference between a good provider and a great one.

Who should choose Claya, and who should skip it

Choose Claya if you specifically want the oral-tablet option, or if clinician and pharmacy transparency is what has been holding you back from compounded GLP-1. The named providers, named pharmacies, and money-back guarantee make it an easier platform to trust than a typical anonymous compounder. Skip it if you need brand-name Wegovy or Zepbound (Claya is compounded-only) or if you want the lowest sustained monthly cost (the locked refill rate undercuts the cheap first month). Skip it, too, if you will not proceed without seeing a LegitScript ID and a clearly disclosed states list up front. If those two matter more to you than the oral option, LifeRx.md is LegitScript certified and serves all 50 states, but it now lists only compounded semaglutide and requires a video consult.

Trust, safety, and what's still missing

The positives are concrete and checkable: transparent pricing with no surprise membership fee, two named clinicians, and two named pharmacy partners with street addresses. The reservations are about disclosure; there is no FDA warning letter on file for Claya. What holds it back is the missing states list, the absent LegitScript certification, and the undisclosed corporate entity. As with any compounded GLP-1, confirm the medication source and the prescribing clinician at checkout, and read how the money-back guarantee pays out before you rely on it. You can see how we weigh these factors in our scoring methodology.

Bottom line

Claya is one of the more transparent compounded GLP-1 platforms, and the oral-tablet option is the main draw for needle-averse patients. Just go in clear-eyed: the headline is a starting price, shipped every 4 weeks, the oral tablets are less proven than the injections, and a few trust credentials are missing. If you value named clinicians and a needle-free choice over rock-bottom pricing, add it to the platforms you compare.

The Bottom Line

Claya scores highest on the strength of its clinical program: drug options and dosing support.

Score: 7.1/10Best for: compounded GLP-1 in injectable and oral-tablet forms with named cliniciansFrom: $149/4 wks (billed per 4 weeks)

Ready to start with Claya?

From $149/4 wks (billed per 4 weeks). See current pricing and start your free consultation.

Claya might not be your best fit if…

We rank editorially, so here’s where a different provider we track may serve you better.

  • If you want brand-name Ozempic, Wegovy, Mounjaro or Zepbound, consider altRX.
  • If the lowest possible monthly price is your top priority, consider YourEra (from $89/mo).
  • If you want built-in coaching and behavior-change support, consider Ro.

Head-to-head

Compare Claya vs…

Claya scores7.1/10

Side-by-side pricing, medications and scores. Pick a matchup.

Scores are our independent editorial ratings out of 10.

Frequently Asked Questions

Claya is a direct-to-consumer telehealth platform offering compounded semaglutide and tirzepatide in both injectable and oral-tablet forms. It publicly names its clinicians (Jennifer Habashy, NMD, MS and Dr. Michael Barber, MD, PhD) and two compounding pharmacy partners; a licensed clinician determines whether treatment is appropriate for you.
No. Claya offers compounded semaglutide and tirzepatide, which are not FDA-approved. Note that compounded oral GLP-1 tablets have weaker efficacy data than injectable semaglutide, so discuss the format options with the clinician.
Claya's monthly plans start at $149 a month for semaglutide and $199 for tirzepatide, shipped every 4 weeks; lower rates need a multi-month plan. Oral tablets start at $279 (semaglutide) and $379 (tirzepatide) for the first month, so the introductory rate does not carry over to refills. A separate concierge membership tier starting around $1,999/month is also advertised.
Claya does not publish a states-served list on its site, so availability is confirmed at checkout for your state.
Claya operates cash-pay with free expedited shipping included, and publishes a weight-loss money-back guarantee on its homepage. Review the guarantee terms before enrolling, since insurance billing is not described.
You complete an online intake in Claya’s doctor-led process, and a named licensed clinician determines whether a compounded GLP-1 is appropriate for you, and in which format, before prescribing.
When we last checked (June 2026), Claya offered code 100CLAYA (Code 100CLAYA: $100 off your first month (GLP-1 from $149/mo)). Apply it on Claya's own checkout via the link on this page, and ignore third-party sites listing other "Claya codes", which are typically fake.
Claya is an operating telehealth provider, and we found no FDA warning letter on file for it. We could not confirm a LegitScript certification from its public pages. We last checked its prices and policies on its own site in October 2026. We scored it 7.1/10 from published information, which is not a clinical endorsement. Talk to a licensed clinician before starting any medication.
We don't collect customer complaints, so this covers what our own review found. There is no FDA warning letter on file for Claya. The concerns our review flags: States-served list not disclosed, so you must check at checkout; LegitScript certification status not displayed; Corporate legal entity not disclosed on the site or privacy policy; Oral compounded tablets have weaker efficacy data than injectable semaglutide. Weigh them before you sign up.

Key terms, explained

New to GLP-1s? Tap any term for a quick, plain-English definition.

Sources

The primary regulatory filings and peer-reviewed studies cited throughout this Claya review:

Sources & methodology (as of November 2026)
  1. 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
  2. 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
  3. 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
  4. 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
  5. 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
  6. 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
  7. 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
  8. 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
  9. 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
  10. 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
  11. 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
  12. 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.

See Claya's current pricing

Plans from $149/4 wks (billed per 4 weeks). Start your free consultation to check eligibility and today's price.